President Donald J. Trump signed an executive order to accelerate access to treatments for patients with serious mental illness, including psychedelics. The order directs the FDA to provide National Priority Vouchers to psychedelic drugs with Breakthrough Therapy designations, ensuring a streamlined review process. It also allocates $50 million through the Advanced Research Projects for Health (ARPAH) program to support state investments in psychedelic research. The order aims to increase clinical trial participation and generate evidence ...
The Slice News/Report is news entitty owned by Jireh Communications Group and is operated, written and or edited by a member of the working press. The content, whether editorial, exclusive or news headlines is both reliable and credible. The companion radio report airs weekly on AM and FM radio dials nationwide. The Slice News is available at www.theslicenews.com. News from the The Slice is posted on Facebook and other social media outlets to inform the public of current news items.